Cancer Home > Cladrobine

Were you looking for information about Cladribine? Cladrobine is a common misspelling of cladribine.
Cladribine (Leustatin®) is a medicine licensed for the treatment of hairy cell leukemia in adults. It is available by prescription only and comes as an injection that is given slowly into a vein (intravenously, or by IV) continuously for seven days.
Before you begin treatment with this chemotherapy drug, your healthcare provider will want to know if you have kidney disease, are pregnant or breastfeeding, or have any allergies. Potential side effects of cladribine include fever, fatigue, and infections.
(Click Cladribine for a closer look at this chemotherapy drug, including how it works, who makes it, and safety precautions. You can also click any of the links in the box to the right for specific information.)
Written by/reviewed by:
Last reviewed by: Kristi Monson, PharmD;
Last updated/reviewed:
List of references (click here):
Other Articles in This eMedTV Presentation




Related Channels

eMedTV Links
Copyright © 2006-2019 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.